SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF
申请人:Accutar Biotechnology Inc.
公开号:EP3795570A1
公开(公告)日:2021-03-24
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.
本公开涉及新型化合物、含有此类化合物的药物组合物及其在预防和治疗癌症及相关疾病和病症中的用途。在某些实施方案中,本文公开的化合物具有雄激素受体降解活性。